1. Home
  2. EWCZ vs PRQR Comparison

EWCZ vs PRQR Comparison

Compare EWCZ & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWCZ
  • PRQR
  • Stock Information
  • Founded
  • EWCZ 2004
  • PRQR 2012
  • Country
  • EWCZ United States
  • PRQR Netherlands
  • Employees
  • EWCZ N/A
  • PRQR N/A
  • Industry
  • EWCZ Package Goods/Cosmetics
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EWCZ Consumer Discretionary
  • PRQR Health Care
  • Exchange
  • EWCZ Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • EWCZ 294.0M
  • PRQR 309.5M
  • IPO Year
  • EWCZ 2021
  • PRQR 2014
  • Fundamental
  • Price
  • EWCZ $5.89
  • PRQR $3.62
  • Analyst Decision
  • EWCZ Buy
  • PRQR Strong Buy
  • Analyst Count
  • EWCZ 7
  • PRQR 4
  • Target Price
  • EWCZ $7.64
  • PRQR $7.13
  • AVG Volume (30 Days)
  • EWCZ 755.4K
  • PRQR 635.3K
  • Earning Date
  • EWCZ 11-14-2024
  • PRQR 11-07-2024
  • Dividend Yield
  • EWCZ N/A
  • PRQR N/A
  • EPS Growth
  • EWCZ 62.57
  • PRQR N/A
  • EPS
  • EWCZ 0.23
  • PRQR N/A
  • Revenue
  • EWCZ $223,500,000.00
  • PRQR $20,506,357.00
  • Revenue This Year
  • EWCZ $0.81
  • PRQR $298.83
  • Revenue Next Year
  • EWCZ $4.02
  • PRQR N/A
  • P/E Ratio
  • EWCZ $25.61
  • PRQR N/A
  • Revenue Growth
  • EWCZ 2.42
  • PRQR 306.68
  • 52 Week Low
  • EWCZ $4.80
  • PRQR $1.18
  • 52 Week High
  • EWCZ $16.07
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • EWCZ 37.35
  • PRQR 54.60
  • Support Level
  • EWCZ $5.38
  • PRQR $3.57
  • Resistance Level
  • EWCZ $6.14
  • PRQR $3.70
  • Average True Range (ATR)
  • EWCZ 0.63
  • PRQR 0.22
  • MACD
  • EWCZ -0.22
  • PRQR -0.08
  • Stochastic Oscillator
  • EWCZ 14.46
  • PRQR 18.06

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Share on Social Networks: